A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors

NCT05086848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Irinotecan liposome、5-fluorouracil、Leucovorin

Sponsor

Jiangsu HengRui Medicine Co., Ltd.